drugset / Trial / NCT00662077

Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort

NCT00662077

Phase 4 Withdrawn Germans Trias i Pujol Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This project wills to determine the incidence of osteoporosis in our population of HIV-infected patients and to assess the efficacy and security of ibandronate, whose efficacy in post-menopausal women has already been proved.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibandronate Other / unclassified 3 mg Intravenous